Mankind Pharma Ltd Quarterly Results

Gross Sales

3,697.16

3,570.35

3,079.37

3,198.79

3,061.43

Excise Duty

0

0

0

0

0

Net Sales

3,697.16

3,570.35

3,079.37

3,198.79

3,061.43

Other Operating Income

0

0

0

0

0

Other Income

94.19

83.05

253.65

87.09

111.63

Total Income

3,791.35

3,653.4

3,333.02

3,285.88

3,173.06

Total Expenditure

2,775.83

2,723.58

2,400.52

2,382.8

2,216.61

PBIDT

1,015.52

929.82

932.5

903.08

956.45

Interest

169.68

170.65

190.54

220.93

7.1

PBDT

845.84

759.17

741.96

682.15

949.35

Depreciation

221.82

218.68

230.87

187.17

100.49

Minority Interest Before NP

0

0

0

0

0

Tax

125.19

110.94

131.51

157.76

168.13

Deferred Tax

-21.35

-15.07

-45.07

-47.3

21.85

Reported Profit After Tax

520.18

444.62

424.65

384.52

658.88

Minority Interest After NP

8.67

6.3

3.88

4.29

5.41

Net Profit after Minority Interest

511.51

438.32

420.77

380.23

653.47

Extra-ordinary Items

0

0

-4.34

6.65

-2.37

Adjusted Profit After Extra-ordinary item

511.51

438.32

425.11

373.58

655.84

EPS (Unit Curr.)

12.39

10.62

10.19

9.46

16.31

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

100

100

0

0

0

Equity

41.28

41.26

41.26

40.06

40.06

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

27.46

26.04

30.28

28.23

31.24

PBDTM(%)

22.87

21.26

24.09

21.32

31.01

PATM(%)

14.06

12.45

13.79

12.02

21.52